Developer docs
API playgroundTry for free, no card

Search company profiles

Plasvacc USA Inc

Full company profile

uuid00546m4

Namestring
Plasvacc USA Inc
Legal namestring
Plasvacc USA Inc
Websiteurl
plasvaccusa.com
Company typeenum
Private
Founded yearstring
-
Descriptiontext

Plasvacc USA Inc is a privately held US-based veterinary biological products company that manufactures hyperimmunized plasma and related blood products for equine and canine patients. The company's core technology is hyperimmunization: donor animals are immunized to reach USDA-specified antibody levels, and the resulting high-IgG, cell-free plasma is never blended and is fully traceable to a single donor. Operations are anchored by a USDA-licensed facility with a quarantined donor herd of approximately 90 horses, using pheresing equipment comparable to human blood collection standards.

The product portfolio is anchored by two registered trademarks: Equiplas® (equine hyperimmunized plasma) and Caniplas® (canine hyperimmunized plasma), supplemented by Equine Whole Blood, diagnostic kits across equine/canine/feline species, lab services, and the Flexineb respiratory device. The company emphasizes label-level IgG transparency as a customer-facing quality claim.

Plasvacc operates a direct-to-veterinarian B2B sales motion, with ordering by phone (+1-800-654-9743) and website, and technical support staffed by practicing veterinarians. The branded commercial footprint extends to affiliated Plasvacc sites in Australia, the UK, and Chile. The company is privately held with no disclosed institutional investors, funding rounds, or revenue figures. Customer segments are veterinary practices — primarily equine healthcare providers and secondarily canine healthcare providers — with no public enterprise customer disclosures and pricing conducted on a quote basis.

Short descriptiontext

Plasvacc USA Inc is a privately held, USDA-licensed veterinary biological products manufacturer that produces hyperimmunized plasma (Equiplas®, Caniplas®) and whole blood from a quarantined donor herd for equine and canine veterinary practices.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
Markets served

Serves global market

Keyword5 values
veterinary plasma products, hyperimmunized plasma therapy, equine blood products, canine plasma biologics, veterinary biological products
Industry3 codes
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)
SIC code1 code
  • Biological Products, (No Disgnostic Substances)2836
Product category
Veterinary Biological Products
Social media profiles2 records
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Veterinary Plasma Products
TypeOne Time License
Description

Sale of hyperimmunized plasma products for veterinary use including equine and canine applications. Products include Equiplas, Caniplas, Equine Whole Blood, and related diagnostic and lab products.

plasvacc.com
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
Pricing details1 tier
1Product pricing available upon inquiry
ModelOtherBilling cadencePay-as-you-go
Notes

Quote-based pricing for veterinary plasma products. No public pricing listed on website.

plasvacc.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 2 records shown
1Equiplas®
Description

USDA-licensed equine plasma product with high IgG antibody levels for natural healing in horses

plasvacc.com
+1 more record
Core offering1 text field

Plasvacc USA Inc manufactures and sells hyperimmunized, cell-free veterinary plasma biologics for equine (Equiplas®) and canine (Caniplas®) use, along with equine whole blood, diagnostic kits, laboratory testing services, and respiratory therapy devices. Products are made at a USDA-licensed facility from a quarantined, USDA-approved donor herd of approximately 90 horses using pheresing equipment comparable to human blood collection, with single-source traceability and IgG antibody levels printed on labels.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • Guaranteed higher IgG levels compared to non-hyperimmunized products
Product overview1 text field

Plasvacc USA is a veterinary biological products company offering a portfolio of hyperimmunized, cell-free plasma products for animals. The core product line centers on two branded plasma products: Equiplas® for equine use and Caniplas® for canine use, both featuring high gamma globulin (IgG) levels and USDA-licensed certification. Supporting offerings include Equine Whole Blood from a donor herd of approximately 90 horses, Diagnostic Kits across equine/canine/feline species, Lab Services, and Flexineb respiratory devices. The company operates a USDA-licensed facility using pheresing equipment similar to human blood collection, with all products featuring single-source traceability and never-blended plasma.

Product and service6 records
1Equiplas®
CategoryVeterinary plasma biologics (equine)
Description

Hyperimmunized equine plasma product with high gamma globulin (IgG) antibody levels, USDA-licensed, with IgG measurements displayed on labels. Designed for equine veterinarians and clinics administering plasma therapy for immunity, protection, and recovery in horses.

2Caniplas®
CategoryVeterinary plasma biologics (canine)
Description

Hyperimmunized canine plasma product offering high antibody levels for immunity and healing; single-source, cell-free, and never blended. Designed for canine veterinary practitioners and clinics treating dogs with conditions requiring elevated antibody support.

3Equine Whole Blood
CategoryVeterinary blood products (equine)
Description

Whole blood product collected from Plasvacc's USDA-approved donor herd of approximately 90 horses for equine transfusion needs. Intended for equine veterinarians performing transfusion procedures.

4Diagnostic Kits
CategoryVeterinary diagnostics
Description

Diagnostic testing kits for equine, canine, and feline health assessment offered by Plasvacc USA. Sold to veterinary clinics and practices for point-of-care and laboratory diagnostic use.

5Lab Services
CategoryVeterinary laboratory services
Description

Laboratory testing services supporting equine health diagnostics and plasma product analysis. Provided to veterinarians and clinics requiring specialized testing beyond in-clinic capabilities.

6Flexineb
CategoryVeterinary respiratory therapy devices
Description

Nebulizer device for equine respiratory therapy, supporting treatment delivery for respiratory conditions in horses. Offered by Plasvacc USA to equine veterinary practitioners.

Scale indicator2 records

Each record includes

Type, Value, Description, Source

Partnership4 partners
1AAEP (American Association of Equine Practitioners)
Strategic tierMinorTypeOthers
Description

Professional membership organization for equine veterinarians. Plasvacc is a proud member, supporting the equine veterinary community.

plasvacc.com
Strategic tierMinorTypeOthers
Description

Professional veterinary technology association. Plasvacc holds membership supporting the veterinary technology community.

3AVHTM
Strategic tierMinorTypeOthers
Description

Association of Veterinary Holistics and Traditional Medicine. Plasvacc membership supports integrative veterinary medicine practitioners.

plasvacc.com
Strategic tierMinorTypeOthers
Description

Veterinary Emergency and Critical Care Society. Plasvacc supports emergency and critical care veterinary professionals through membership.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global animal health company with veterinary specialty pharmaceuticals including equine products. Comparable B2B veterinary sales motion and equine focus, though broader in therapeutic categories.

TypeBroad incumbent
Description

Major global animal health company with companion animal and equine therapeutics. Comparable in veterinary channel and biologics presence, though much larger and broader in product scope.

TypeBroad incumbent
Description

Global veterinary pharmaceutical company with a strong equine portfolio. Comparable in targeting equine veterinary practices with specialty therapeutics, though far larger and broader in product scope than Plasvacc.

TypeDirect peer
Description

Manufacturer of hyperimmune plasma products for small and large animals. Comparable product technology (hyperimmunized plasma) and similar veterinary distributor channel, though broader species coverage.

TypeBroad incumbent
Description

Specialty veterinary pharmaceuticals company with equine and companion animal therapeutic lines. Comparable end customers (veterinary practices) and specialty pharma positioning, though plasma is not a core product.

TypeBroad incumbent
Description

Largest global animal health company with extensive equine and companion animal biologics portfolios. Overlaps with Plasvacc in equine veterinary biologics and plasma-derived products, though as part of a much wider portfolio.

7Ardent Animal Health
TypeEmerging player
Description

Veterinary plasma and blood product supplier for animal health applications. Comparable in product category (animal plasma products) and customer base (veterinary practices).

TypeEmerging player
Description

Major veterinary diagnostics company that also offers equine-focused diagnostic and lab services. Comparable in the diagnostic kits and lab services adjacencies Plasvacc offers alongside its core plasma products.

TypeDirect peer
Description

UK-based producer of hyperimmune equine plasma products for veterinary use. Most directly comparable peer — same hyperimmunized plasma technology, same equine veterinary customer base, and overlapping UK/US distribution.

10Boehringer Ingelheim Animal Health
TypeBroad incumbent
Description

Global animal health division of Boehringer Ingelheim with veterinary biologics and equine products. Overlaps in biologics category and veterinary channel, though operates at vastly larger scale and broader portfolio.

Market position
Strengths4 records

Each record includes

Headline, Details, Source

Weaknesses4 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks5 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature3 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
No data
Compliance1 record

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Plasvacc USA Inc

Veterinary Biological Productsplasvaccusa.com

Plasvacc USA Inc is a privately held, USDA-licensed veterinary biological products manufacturer that produces hyperimmunized plasma (Equiplas®, Caniplas®) and whole blood from a quarantined donor herd for equine and canine veterinary practices.

What Plasvacc USA Inc does

Plasvacc USA Inc is a privately held US-based veterinary biological products company that manufactures hyperimmunized plasma and related blood products for equine and canine patients. The company's core technology is hyperimmunization: donor animals are immunized to reach USDA-specified antibody levels, and the resulting high-IgG, cell-free plasma is never blended and is fully traceable to a single donor. Operations are anchored by a USDA-licensed facility with a quarantined donor herd of approximately 90 horses, using pheresing equipment comparable to human blood collection standards.

The product portfolio is anchored by two registered trademarks: Equiplas® (equine hyperimmunized plasma) and Caniplas® (canine hyperimmunized plasma), supplemented by Equine Whole Blood, diagnostic kits across equine/canine/feline species, lab services, and the Flexineb respiratory device. The company emphasizes label-level IgG transparency as a customer-facing quality claim.

Plasvacc operates a direct-to-veterinarian B2B sales motion, with ordering by phone (+1-800-654-9743) and website, and technical support staffed by practicing veterinarians. The branded commercial footprint extends to affiliated Plasvacc sites in Australia, the UK, and Chile. The company is privately held with no disclosed institutional investors, funding rounds, or revenue figures. Customer segments are veterinary practices — primarily equine healthcare providers and secondarily canine healthcare providers — with no public enterprise customer disclosures and pricing conducted on a quote basis.

Plasvacc USA Inc firmographics

Firmographics
Name
Plasvacc USA Inc
Legal name
Plasvacc USA Inc
Website
https://plasvaccusa.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
Plasvacc USA Inc is a privately held, USDA-licensed veterinary biological products manufacturer that produces hyperimmunized plasma (Equiplas®, Caniplas®) and whole blood from a quarantined donor herd for equine and canine veterinary practices.
Ownership category
akta.pro rank

Plasvacc USA Inc industry classification

Industry
Product category
Veterinary Biological Products
SIC
Biological Products, (No Disgnostic Substances) (2836)
akta.pro industry
PRIMARYHLAMAEAK
Biologics & Immunotherapies (Non-vaccine)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAEAC
Equine Therapeutics (Rx)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Pharmaceuticals & Biologics
SECONDARYHLAMAIAH
Specialty Veterinary Therapeutics Distribution (Oncology, Dermatology, Endocrinology)
Healthcare & Life Sciences/Veterinary & Animal Health/Veterinary Distribution & Retail (Wholesalers, Pharmacies)

Keywords

  • Veterinary plasma products
  • Hyperimmunized plasma therapy
  • Equine blood products
  • Canine plasma biologics
  • Veterinary biological products

Plasvacc USA Inc business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Veterinary Plasma Products: Sale of hyperimmunized plasma products for veterinary use including equine and canine applications. Products include Equiplas, Caniplas, Equine Whole Blood, and related diagnostic and lab products.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goProduct pricing available upon inquiry

Go-to-market motion1 record

Distribution channels1 record

Marketing channels4 records

Plasvacc USA Inc product offering

Product offering

Core offering

Plasvacc USA Inc manufactures and sells hyperimmunized, cell-free veterinary plasma biologics for equine (Equiplas®) and canine (Caniplas®) use, along with equine whole blood, diagnostic kits, laboratory testing services, and respiratory therapy devices. Products are made at a USDA-licensed facility from a quarantined, USDA-approved donor herd of approximately 90 horses using pheresing equipment comparable to human blood collection, with single-source traceability and IgG antibody levels printed on labels.

Product overview

Plasvacc USA is a veterinary biological products company offering a portfolio of hyperimmunized, cell-free plasma products for animals. The core product line centers on two branded plasma products: Equiplas® for equine use and Caniplas® for canine use, both featuring high gamma globulin (IgG) levels and USDA-licensed certification. Supporting offerings include Equine Whole Blood from a donor herd of approximately 90 horses, Diagnostic Kits across equine/canine/feline species, Lab Services, and Flexineb respiratory devices. The company operates a USDA-licensed facility using pheresing equipment similar to human blood collection, with all products featuring single-source traceability and never-blended plasma.

Differentiator

Problem solved

Functional benefit

Brands

  • Equiplas®: USDA-licensed equine plasma product with high IgG antibody levels for natural healing in horses
  • Caniplas®

Products and services

  • Equiplas® Hyperimmunized equine plasma product with high gamma globulin (IgG) antibody levels, USDA-licensed, with IgG measurements displayed on labels. Designed for equine veterinarians and clinics administering plasma therapy for immunity, protection, and recovery in horses.
  • Caniplas® Hyperimmunized canine plasma product offering high antibody levels for immunity and healing; single-source, cell-free, and never blended. Designed for canine veterinary practitioners and clinics treating dogs with conditions requiring elevated antibody support.
  • Equine Whole Blood Whole blood product collected from Plasvacc's USDA-approved donor herd of approximately 90 horses for equine transfusion needs. Intended for equine veterinarians performing transfusion procedures.
  • Diagnostic Kits Diagnostic testing kits for equine, canine, and feline health assessment offered by Plasvacc USA. Sold to veterinary clinics and practices for point-of-care and laboratory diagnostic use.
  • Lab Services Laboratory testing services supporting equine health diagnostics and plasma product analysis. Provided to veterinarians and clinics requiring specialized testing beyond in-clinic capabilities.
  • Flexineb Nebulizer device for equine respiratory therapy, supporting treatment delivery for respiratory conditions in horses. Offered by Plasvacc USA to equine veterinary practitioners.

Quantifiable outcome

  • Guaranteed higher IgG levels compared to non-hyperimmunized products

Companies that use Plasvacc USA Inc

Customer profile

Segments3 records

Ideal customer profiles1 record

Plasvacc USA Inc technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature3 records

Plasvacc USA Inc partnerships and signals

Strategic signal

Partnerships

Four partnerships are on record, tiered minor.

  • AAEP (American Association of Equine Practitioners)minorOthersProfessional membership organization for equine veterinarians. Plasvacc is a proud member, supporting the equine veterinary community.
  • AA EVTminorOthersProfessional veterinary technology association. Plasvacc holds membership supporting the veterinary technology community.
  • AVHTMminorOthersAssociation of Veterinary Holistics and Traditional Medicine. Plasvacc membership supports integrative veterinary medicine practitioners.
  • VECCSminorOthersVeterinary Emergency and Critical Care Society. Plasvacc supports emergency and critical care veterinary professionals through membership.

Scale indicators2 records

Recent moves5 records

Expansion highlights4 records

Plasvacc USA Inc competitors and assessment

Company assessment

Broad incumbents

  • Virbac: Global animal health company with veterinary specialty pharmaceuticals including equine products. Comparable B2B veterinary sales motion and equine focus, though broader in therapeutic categories.
  • Elanco Animal Health: Major global animal health company with companion animal and equine therapeutics. Comparable in veterinary channel and biologics presence, though much larger and broader in product scope.
  • Vetoquinol: Global veterinary pharmaceutical company with a strong equine portfolio. Comparable in targeting equine veterinary practices with specialty therapeutics, though far larger and broader in product scope than Plasvacc.
  • Dechra Pharmaceuticals: Specialty veterinary pharmaceuticals company with equine and companion animal therapeutic lines. Comparable end customers (veterinary practices) and specialty pharma positioning, though plasma is not a core product.
  • Zoetis: Largest global animal health company with extensive equine and companion animal biologics portfolios. Overlaps with Plasvacc in equine veterinary biologics and plasma-derived products, though as part of a much wider portfolio.
  • Boehringer Ingelheim Animal Health: Global animal health division of Boehringer Ingelheim with veterinary biologics and equine products. Overlaps in biologics category and veterinary channel, though operates at vastly larger scale and broader portfolio.

Direct peers

  • Lake Immunogenics: Manufacturer of hyperimmune plasma products for small and large animals. Comparable product technology (hyperimmunized plasma) and similar veterinary distributor channel, though broader species coverage.
  • Veterinary Immunogenics: UK-based producer of hyperimmune equine plasma products for veterinary use. Most directly comparable peer — same hyperimmunized plasma technology, same equine veterinary customer base, and overlapping UK/US distribution.

Emerging players

  • Ardent Animal Health: Veterinary plasma and blood product supplier for animal health applications. Comparable in product category (animal plasma products) and customer base (veterinary practices).
  • IDEXX Laboratories: Major veterinary diagnostics company that also offers equine-focused diagnostic and lab services. Comparable in the diagnostic kits and lab services adjacencies Plasvacc offers alongside its core plasma products.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

Plasvacc USA Inc social profiles

Digital presence

Plasvacc USA Inc compliance and trust

Trust signal

Compliance1 record

Plasvacc USA Inc financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Plasvacc USA Inc leadership team

Management profile

Number of profiles

Plasvacc USA Inc funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Plasvacc USA Inc M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Plasvacc USA Inc

What does Plasvacc USA Inc do?

Plasvacc USA Inc manufactures and sells hyperimmunized, cell-free veterinary plasma biologics for equine (Equiplas®) and canine (Caniplas®) use, along with equine whole blood, diagnostic kits, laboratory testing services, and respiratory therapy devices. Products are made at a USDA-licensed facility from a quarantined, USDA-approved donor herd of approximately 90 horses using pheresing equipment comparable to human blood collection, with single-source traceability and IgG antibody levels printed on labels.

Is Plasvacc USA Inc a public or private company?

Plasvacc USA Inc is a private company. It is classified as unknown and is currently operating.

When was Plasvacc USA Inc founded?

Plasvacc USA Inc was founded in -1. It employs 1 to 10 people.

How does Plasvacc USA Inc make money?

One revenue line is on record: veterinary Plasma Products.

Who are Plasvacc USA Inc's main competitors?

Broad incumbents on record are Virbac, Elanco Animal Health, Vetoquinol, Dechra Pharmaceuticals, Zoetis and Boehringer Ingelheim Animal Health. Direct peers are Lake Immunogenics and Veterinary Immunogenics. Emerging players are Ardent Animal Health and IDEXX Laboratories.

Does Plasvacc USA Inc have an API?

No public API is recorded for Plasvacc USA Inc.

What industry is Plasvacc USA Inc in?

Plasvacc USA Inc's product category is Veterinary Biological Products. Its primary akta.pro industry code is HLAMAEAK, Biologics & Immunotherapies (Non-vaccine), with a secondary code of HLAMAEAC, Equine Therapeutics (Rx). Its SIC code is 2836.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales